Stockscreener 앱 받기
87.31
1.62%
-1.44
전일 마감가:
$88.75
열려 있는:
$88.505
하루 거래량:
2.67M
Relative Volume:
1.25
시가총액:
$17.30B
수익:
$7.83B
순이익/손실:
$825.20M
주가수익비율:
21.26
EPS:
4.1067
순현금흐름:
$1.05B
1주 성능:
-5.97%
1개월 성능:
-3.96%
6개월 성능:
-7.33%
1년 성능:
-19.85%
1일 변동 폭
$87.31
$89.28
1주일 범위
$85.76
$93.62
52주 변동 폭
$85.33
$114.44
짐머 바이오메트 Stock (ZBH) Company Profile
명칭
Zimmer Biomet Holdings Inc
전화
(574) 267-6131
주소
345 EAST MAIN STREET, WARSAW, IN
ZBH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
87.31 | 17.59B | 7.83B | 825.20M | 1.05B | 4.1067 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
짐머 바이오메트 Stock (ZBH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2026-01-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-09-18 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-07-15 | 업그레이드 | Roth Capital | Neutral → Buy |
| 2024-12-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Peer Perform |
| 2024-07-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-21 | 업그레이드 | Argus | Hold → Buy |
| 2024-01-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2023-10-20 | 개시 | ROTH MKM | Neutral |
| 2023-08-28 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-05-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-04-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-31 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-03-29 | 개시 | UBS | Sell |
| 2023-03-10 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Underweight |
| 2022-10-12 | 개시 | Jefferies | Underperform |
| 2022-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2022-04-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-03-02 | 재개 | BofA Securities | Underperform |
| 2022-03-02 | 다운그레이드 | Loop Capital | Buy → Hold |
| 2022-02-08 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | 재확인 | Citigroup | Buy |
| 2022-02-08 | 재확인 | Deutsche Bank | Hold |
| 2022-02-08 | 재확인 | JMP Securities | Mkt Outperform |
| 2022-02-08 | 재확인 | JP Morgan | Neutral |
| 2022-02-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | 재확인 | Stifel | Buy |
| 2022-02-08 | 재확인 | Truist | Buy |
| 2022-02-08 | 재확인 | UBS | Neutral |
| 2022-02-08 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-01-19 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-11-23 | 다운그레이드 | Argus | Buy → Hold |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-09 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-12-18 | 재확인 | Needham | Strong Buy |
| 2020-10-20 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Outperform |
| 2020-08-05 | 재확인 | Needham | Strong Buy |
| 2020-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-04-09 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2020-04-07 | 재확인 | Needham | Strong Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2020-01-07 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2019-09-18 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | 업그레이드 | Argus | Hold → Buy |
| 2019-07-30 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | 업그레이드 | Needham | Buy → Strong Buy |
모두보기
짐머 바이오메트 주식(ZBH)의 최신 뉴스
Minneapolis Portfolio Management Group LLC Has $26.02 Million Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet (ZBH) Mixes Executive Exit With Big DTC Push Is Management Rewriting Its Playbook? - simplywall.st
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2025 Financial Results - BioSpace
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock - sharewise.com
What is the dividend yield of Zimmer Biomet Holdings IncQuarterly Trade Report & Long-Term Capital Growth Ideas - baoquankhu1.vn
Buyback Watch: What is the dividend yield of Zimmer Biomet Holdings Inc2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Zimmer Biomet’s Q3 2025 earnings: What to expect - MSN
Zimmer Biomet Announces Q4 2026 Earnings Call Date - Intellectia AI
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US - Yahoo Finance
Is Executive Exit And Cautious Guidance Altering The Investment Case For Zimmer Biomet (ZBH)? - Yahoo Finance
JPM26: Zimmer Biomet reveals plans for largest patient campaign in its history - Yahoo Finance
Zimmer Biomet (ZBH) Ensures Cautious Outlook for 2026 Transforma - GuruFocus
Zimmer Biomet (ZBH) Cautions Investors Ahead of Earnings Release - GuruFocus
Zimmer Biomet down after cautious remarks on outlook (ZBH:NYSE) - Seeking Alpha
Setup Watch: Can Zimmer Biomet Holdings Inc stock outperform in 2025 bull marketEarnings Trend Report & AI Enhanced Trading Signals - moha.gov.vn
Zimmer Biomet’s Q3 2025 Earnings: What to Expect - Yahoo Finance
Daily CourierZimmer Biomet’s Q3 2025 Earnings: What to Expect - FinancialContent
Zimmer Biomet Holdings Inc (NYSE:ZBH) Screened as a 'Decent Value' Investment Opportunity - Chartmill
Zimmer Biomet Holdings, Inc. $ZBH Shares Sold by Nisa Investment Advisors LLC - MarketBeat
Dip Buying: Will Zimmer Biomet Holdings Inc outperform its industry peersPortfolio Performance Report & Comprehensive Market Scan Insights - baoquankhu1.vn
Published on: 2026-01-13 03:09:07 - Улправда
Zimmer Biomet Holdings Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
Zimmer Biomet Holdings (ZBH) Announces Executive Resignation - GuruFocus
Zimmer Biomet Holdings (ZBH): Growth Potential in the Medical Device Sector Amidst Analyst Consensus - DirectorsTalk Interviews
The Truth About Zimmer Biomet: Is This ‘Boring’ Stock Your Next Silent Money Machine? - AD HOC NEWS
Zimmer Biomet Holdings, Inc. $ZBH Shares Acquired by SG Americas Securities LLC - MarketBeat
Nasdaq Moves: What earnings margins imply for Zimmer Biomet Holdings Inc. (ZIM) stockJuly 2025 News Drivers & Community Consensus Stock Picks - ulpravda.ru
RBC Capital Keeps Their Buy Rating on Zimmer Biomet Holdings (ZBH) - The Globe and Mail
Zimmer Biomet (ZBH): Bernstein Raises Price Target Amid Stable R - GuruFocus
Is Renewed Analyst Optimism Reframing Zimmer Biomet’s (ZBH) Modest Growth Into a Differentiated Execution Story? - Sahm
Bernstein Adjusts Price Target on Zimmer Biomet to $99 From $97, Maintains Market Perform Rating - marketscreener.com
HOKA Size Guide: What earnings margins imply for Zimmer Biomet Holdings Inc. (ZIM) stockLong Run Comfort Guide & stability guidance for smoother miles - ulpravda.ru
Zimmer Biomet Holdings, Inc. $ZBH is Oak Family Advisors LLC's 10th Largest Position - MarketBeat
Goldman Sachs Downgrades Zimmer Biomet to Sell From Neutral, Adjusts Price Target to $93 From $97 - marketscreener.com
Zimmer Biomet (ZBH) Valuation Check After Fresh Evercore Upgrade To Outperform - Yahoo Finance
Why Zimmer Biomet Holdings Inc. stock could benefit from AI revolutionQuarterly Trade Review & Precise Entry and Exit Recommendations - ulpravda.ru
What risks investors should watch in Zimmer Biomet Holdings Inc. stockJuly 2025 Recap & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Zimmer Biomet Holdings Inc. (ZIM) stock appeals to dividend investorsCEO Change & Precise Buy Zone Tips - ulpravda.ru
BTIG Research Reiterates "Buy" Rating for Zimmer Biomet (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings (ZBH) Rating Reiterated at 'Buy' by BTIG - GuruFocus
Zimmer Biomet inks a partnership with PatientIQ - MassDevice
Why Zimmer Biomet Holdings Inc. (ZIM) stock is a strong analyst pickMarket Rumors and News & High Profit Market Ideas - ulpravda.ru
Published on: 2026-01-07 19:33:36 - ulpravda.ru
Sivik Global Healthcare LLC Buys New Position in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Absher Wealth Management LLC Invests $2.34 Million in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat
Zimmer Biomet Holdings (XSWX:ZBH) EV-to-OCF : 14.18 (As of Jan. 06, 2026) - GuruFocus
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet stock: Is ZBH underperforming the health care sector? - MSN
Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - simplywall.st
Raymond James Downgrades Zimmer Biomet to Market Perform From Outperform - marketscreener.com
Zimmer Biomet (ZBH) director Louis Shapiro gains phantom stock units - Stock Titan
짐머 바이오메트 (ZBH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
짐머 바이오메트 주식 (ZBH) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Upadhyay Suketu | Exec VP, CFO |
Nov 10 '25 |
Option Exercise |
0.00 |
10,632 |
0 |
59,485 |
| Yi Sang | Group President, Asia Pacific |
Sep 11 '25 |
Sale |
103.58 |
1,200 |
124,302 |
18,584 |
0.42%
1.96%
자본화:
|
볼륨(24시간):